Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ·Healthcare·Biotechnology
$49.63
-14.27%
Mkt Cap $8.22B
Analyst Ratings
Buy
14
Hold
0
Sell
0
Price Target (37 analysts)
$104.43
Range $46.00 – $126.00
Implied Upside
+110.4%
Consensus $104.43 vs current $49.63